Phase II Study of Low-Dose Docetaxel/Fluorouracil/Cisplatin in Metastatic Gastric Carcinoma
Sook Ryun Park(Ulsan College), Hark Kyun Kim(National Cancer Center), Chan Gyoo Kim(National Cancer Center), Jae-Moon Bae(Samsung Medical Center), Il Ju Choi(National Cancer Center), Young‐Woo Kim(Seoul National University Hospital), Jun Ho Lee(National Cancer Center), Jong Ho Chun(Johns Hopkins University), Jong Seok Lee(Brigham and Women's Hospital)
Cited by 44
Related Papers
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)
|Journal of Clinical Oncology|2021|818
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
|The Lancet Oncology|2022|738
Improved Quality of Life Outcomes After Laparoscopy-Assisted Distal Gastrectomy for Early Gastric Cancer
|Annals of Surgery|2008|609